Clinical trial
Uric Acid in Essential Hypertension in Children
NCT00288184 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00288184 |
|---|---|
| Title | Uric Acid in Essential Hypertension in Children |
| Official title | Randomized Double-blinded, Placebo-controlled, Cross-over Trial of Allopurinol for the Treatment of Newly Diagnosed Essential Hypertension in Adolescents |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Baylor University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug |
| Interventions | Allopurinol, Placebo |
| Enrollment | 30 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Feb 7, 2006 |
| Last update posted | Sep 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: